Bio-Rad Laboratories (BIO) reported fourth quarter net income of $1.65 per share after the close Tuesday, down from $2.08 per share last year. The consensus estimate was for EPS of $1.34.
Bio-Rad Laboratories spiked to the upside in early trade Wednesday, but settled into a range for the majority of the session. Shares finished up by 6.25 at $123.55. The stock surged to a new high for the year on the highest volume in 2 months.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.